HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s budget in limbo

This article was originally published in The Rose Sheet

Executive Summary

The 109th Congress failed to pass appropriations for FDA for FY 2007, instead settling on a continuing resolution that expires Feb. 15. Incoming Democratic Appropriations Committee Chairmen Sen. Robert Byrd (W.Va.) and Rep. Dave Obey (Wisc.) plan to scrap the current Republican appropriations bills in favor of a year-long continuing resolution. The move would effectively freeze the agency's spending at FY 2006 levels until FY 2008 begins. FDA responded by stating that "a full-year continuing resolution presents difficult challenges." The agency added that between now and Feb. 15, it "will be working with the administration to analyze the impacts of a continuing resolution"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel